BrainStorm Cell Therapeutics
BCLI
#10412
Rank
NZ$10.36 M
Marketcap
NZ$0.94
Share price
-3.57%
Change (1 day)
-74.13%
Change (1 year)

Earnings for BrainStorm Cell Therapeutics (BCLI)

Earnings in 2025 (TTM): -NZ$18.73 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$20.22 Million, an increase over its 2023 earnings that were of -NZ$29.9 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BrainStorm Cell Therapeutics from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$18.73 Million-7.39%
2024 -NZ$20.22 Million-32.39%
2023 -NZ$29.9 Million-29.18%
2022 -NZ$42.23 Million-0.74%
2021 -NZ$42.54 Million-23.12%
2020 -NZ$55.33 Million36.8%
2019 -NZ$40.44 Million66.71%
2018 -NZ$24.26 Million181.66%
2017 -NZ$8.62 Million-0.6%
2016 -NZ$8.67 Million-41.31%
2015 -NZ$14.77 Million-8.22%
2014 -NZ$16.09 Million89.74%
2013 -NZ$8.48 Million42.27%
2012 -NZ$5.96 Million-12.45%
2011 -NZ$6.81 Million63.04%
2010 -NZ$4.18 Million35.52%
2009 -NZ$3.08 Million-48.99%
2008 -NZ$6.04 Million-44.39%
2007 -NZ$10.86 Million
2005 -NZ$5.63 Million-91.44%
2004 -NZ$65.71 Million94007.62%
2003 -NZ$0.07 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
NZ$17.19 B-91,248.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-NZ$1.31 Billion 6,832.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-NZ$1.38 Billion 7,189.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$3.31 B-17,654.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
NZ$35.93 M-290.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
-NZ$0.45 Billion 2,255.61%๐Ÿ‡บ๐Ÿ‡ธ USA